Logo ČVUT
CZECH TECHNICAL UNIVERSITY IN PRAGUE
STUDY PLANS
2023/2024

Health Technology Assessment

The course is not on the list Without time-table
Code Completion Credits Range Language
F7PMS1HZT Z,ZK 4 2P+2S Czech
Garant předmětu:
Lecturer:
Tutor:
Supervisor:
Department of Biomedical Technology
Synopsis:
Requirements:

Seminar: active participation, test

Exam: written test with open questions as a gateway to the oral exam; the result of the exam (pass/fail) and grade are decided according to the oral part

Syllabus of lectures:

• Introduction to HTA: Role of HTA, historical overview. Definition of HTA: definition of HTA, basic focus of HTA, perspective of the study of HTA. What does HTA assess? The use of HTA for deciding on the inclusion of new technology in health insurance reimbursements. Use of HTA for strategic decision-making in hospitals. Separation of evaluation from decision making.

• Evidence-based medicine. Quality of information sources in EBM. Literature search: literature search technique, database of publications and scientific results, Cochrane Institute. Meta-analysis and its techniques. Data sources: international database, ÚZIS, retrospective data from care providers and payers.

• Outcomes in the area of ​​HTA: how to obtain them, how to process them, how to calculate them. Types that can be used within HTA.

• Multicriteria methods for determining outcomes. Quality of life measurement: QALY, DALY, LYG, way of measuring quality of life, generic questionnaires, specific questionnaires, time trade-off, standard gamble.

• Costs and sources of cost data: Direct medical costs, direct non-medical costs. Indirect costs, incalculable costs.

• Cost analyses: CMA, CEA, CUA, ICER, CBA, CIA, CCA. Economic-theoretical foundations of cost analyses. Modeling in HTA. Sensitivity analyses.

• Core model. NICE model. HTA for medicinal products.

• Use of HTA studies for deciding on the inclusion of new technology in payments from public health insurance. Introducing new technology to health insurance payments. Disinvestment. Budget Impact Analysis (BIA). Willingness to pay - willingness to pay. Threshold values ​​and their introduction. Individual limits of willingness to pay

• HTA for medical devices. Appropriate analysis, assessment process. HB-HTA: Use of HTA at hospital level.

• Organization and cooperation in the field of HTA: Organization of HTA at the national level, transfer of HTA results between national health systems. International organisation. HTA ethics.

Syllabus of tutorials:

• Literary research and meta-analysis. Practical examples and working with data.

• Outcomes - value engineering, multi-criteria decision-making.

• Outcomes - QALYs. Processing questionnaire surveys.

• Costs: Direct medical costs, direct non-medical costs.

• Indirect costs, incalculable costs - practical examples.

• CEA and ICER - practical examples.

• CEA and ICER - practical examples of continuation.

• CBA - practical examples.

• CMA, CUA - practical examples.

• Evaluation of medical devices - practical examples.

Study Objective:
Study materials:

Required reading

[1] GOODMAN, Clifford S.: HTA101. Introduction to Health Technology Assessment. The Lewin Group, Virginia, 2014. (Freely available from http://www.nlm.nih.gov/nichsr/hta101/HTA_101_FINAL_7-23-14.pdf)

[2] BRENT, Robert J. Cost-benefit analysis and health care evaluations. Northhampton, MA: Edward Elgar, 2014. ISBN 9781781004586.

[3] SCHÖFFSKI, Oliver and Johann-Matthias SCHULENBURG. Gesundheitsökonomische Evaluationnen. 4., completely überarb. Aufl. Berlin: Springer, 2012. ISBN 978-3-642-21699-2.

Study aids

Supports intended for the combined form of study and presentation published on the website of the subject.

Note:
Further information:
No time-table has been prepared for this course
The course is a part of the following study plans:
Data valid to 2024-07-26
Aktualizace výše uvedených informací naleznete na adrese https://bilakniha.cvut.cz/en/predmet7789806.html